Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Bangalore cohort of the A1chieve study
- PMID: 24404503
- PMCID: PMC3872911
- DOI: 10.4103/2230-8210.122135
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Bangalore cohort of the A1chieve study
Abstract
Background: The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents.
Materials and methods: Data was collected at baseline, at 12 weeks and at 24 weeks. This short communication presents the results for patients enrolled from Bangalore, India.
Results: A total of 1533 patients were enrolled in the study. Four different insulin analogue regimens were used in the study. Patients had started on or were switched to biphasic insulin aspart (n = 1262), insulin detemir (n = 165), insulin aspart (n = 86), basal insulin plus insulin aspart (n = 11) and other insulin combinations (n = 2). At baseline glycaemic control was poor for both insulin naïve (mean HbA1c: 9.2%) and insulin users (mean HbA1c: 8.8%) groups. After 24 weeks of treatment, both groups showed improvement in HbA1c (insulin naïve: -1.3%, insulin users: -1.5%). SADRs including major hypoglycaemic events or episodes did not occur in any of the study patients.
Conclusion: Starting or switching to insulin analogues was associated with improvement in glycaemic control with a low rate of hypoglycaemia.
Keywords: A1chieve study; Bangalore; insulin analogues; type 2 diabetes mellitus.
Conflict of interest statement
References
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. - PubMed
-
- Shetty P. Public health: India's diabetes time bomb. Nature. 2012;485:S14–6. - PubMed
-
- Korytkowski M. When oral agents fail: Practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(Suppl 3):S18–24. - PubMed
-
- Hirsch IB. Insulin analogues. N Engl J Med. 2005;352:174–83. - PubMed
-
- Shah SN, Litwak L, Haddad J, Chakkarwar PN, Hajjaji I. The A 1 chieve study: A 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice. Diabetes Res Clin Pract. 2010;88:S11–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources